Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$9.20 USD
+0.24 (2.68%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $11.01 +1.81 (19.67%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: AMC |
9/2024 | $0.49 | 0.00% |
Earnings Summary
For their last quarter, Emergent Biosolutions (EBS) reported earnings of $1.37 per share, beating the Zacks Consensus Estimate of $0.49 per share. This reflects a positive earnings surprise of 179.59%. Look out for EBS's next earnings release expected on March 05, 2025. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year increase of 134.03%.
Earnings History
Price & Consensus
Zacks News for EBS
Apellis Pharmaceuticals, Inc. (APLS) Reports Q3 Loss, Lags Revenue Estimates
EBS: What are Zacks experts saying now?
Zacks Private Portfolio Services